Xenetic Biosciences, Inc. (XBIO) News
Track canonical SquawkNews coverage tagged to XBIO, Xenetic Biosciences, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Xenetic Biosciences to merge with Santersus in all-stock deal
Xenetic Biosciences agreed to combine with privately held therapeutic medical-device company Santersus in an all-stock reverse merger. Xenetic said Santersus investors would own about 85% of the combined company, while c
EQUITY | Sep 16, 2026, 11:30 AM UTC
M
Xenetic Biosciences to acquire Santersus in all-stock exchange
Xenetic Biosciences entered a definitive all-stock share exchange to acquire Santersus, with pro forma ownership of ~15% for Xenetic holders and ~85% for Santersus holders, subject to approvals.
EQUITY | Sep 16, 2026, 11:03 AM UTC